Community-Acquired Pneumonia
A comprehensive nursing reference on Community-Acquired Pneumonia (CAP), covering pathophysiology, etiology and pathogens, risk stratification (CURB-65), clinical presentation, diagnostic studies, nursing assessment and interventions, pharmacological management, complications, and patient education for BSN-prepared nurses. Includes NCLEX-NG formative check questions.
Overview
Community-Acquired Pneumonia (CAP) is an acute infectious inflammation of the lung parenchyma that is acquired outside of a hospital or healthcare facility, or within 48 hours of hospital admission in a patient who has not resided in a long-term care facility for 14 or more days. CAP is one of the most prevalent and clinically significant infectious diseases encountered in nursing practice across all acuity settings — from the outpatient clinic to the medical-surgical unit and the intensive care unit (ICU).
CAP represents the leading cause of infectious disease death in the United States and is the most common cause of sepsis. It affects approximately 5–6 million adults annually in the United States, resulting in more than 1.5 million hospitalizations and contributing to approximately 50,000 deaths per year. Globally, pneumonia is responsible for more deaths than any other infectious disease, particularly among the very young and the very old. Despite advances in vaccination and antimicrobial therapy, CAP continues to carry a significant mortality burden — approximately 5–12% in hospitalized patients and up to 30–50% in those who require ICU admission.
For the BSN-prepared nurse, CAP represents a high-priority clinical judgment challenge at every stage of illness. The nurse must recognize early warning signs of deterioration, prioritize diagnostic specimen collection before antibiotic initiation, apply oxygenation management principles matched to severity, and provide individualized education that promotes vaccination and prevents recurrence. Mastery of CAP pathophysiology, risk stratification, and evidence-based management is an essential component of medical-surgical and critical care nursing competency and is consistently tested on the NCLEX-NG.
Clinical Alert
CAP is the leading infectious cause of death in the United States and the most common precipitant of sepsis. Early recognition, prompt specimen collection, and timely antibiotic administration are the nurse’s most critical contributions to reducing mortality.
Pathophysiology
Normal Respiratory Defense Mechanisms
The respiratory tract possesses a layered defense system that normally prevents microorganisms from reaching the gas-exchange surfaces of the lung. Understanding these defenses clarifies how CAP develops when one or more layers fail.
- Upper airway mechanical barriers: Nasal hair, turbinates, and the mucociliary escalator of the trachea and bronchi trap and expel inhaled particles before they reach the lower airways.
- Cough and epiglottic reflexes: Coordinated cough and epiglottic closure prevent aspiration of oropharyngeal contents into the lower respiratory tract.
- Mucociliary clearance: Ciliated respiratory epithelium continuously propels a mucus layer containing trapped pathogens toward the pharynx for swallowing or expectoration.
- Alveolar macrophages: Resident alveolar macrophages phagocytose pathogens and debris that reach the alveoli, initiating an inflammatory response and recruiting additional immune effector cells.
- Immunoglobulin A (IgA): Secretory IgA on mucosal surfaces neutralizes pathogens and prevents adherence to epithelial cells.
Failure of Host Defenses and Microbial Entry
CAP occurs when the pathogen load or virulence overwhelms these defense mechanisms, or when host defenses are compromised. The predominant routes of entry are:
- Microaspiration of oropharyngeal contents: The most common mechanism. Even healthy adults silently aspirate small volumes of secretions during sleep; in vulnerable hosts (elderly, sedated, dysphagic), aspiration of colonized oropharyngeal flora overwhelms local defenses.
- Inhalation of infectious aerosols: Particularly relevant for atypical pathogens (Mycoplasma, Legionella, Chlamydophila) and viruses (influenza, SARS-CoV-2), which are transmitted by fine respiratory droplets or aerosols.
- Hematogenous spread: Less common; occurs when organisms seed the lung from a distant bacteremic source (e.g., right-sided endocarditis, septic thrombophlebitis).
Alveolar Consolidation
Once a pathogen establishes infection in the lower respiratory tract, the host mounts an inflammatory response. Inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) recruit neutrophils and monocytes to the alveoli. The resulting exudate — composed of fibrin, red blood cells, neutrophils, and bacteria — fills the alveolar spaces and displaces air. This process is called consolidation.
In typical (bacterial) pneumonia, consolidation follows anatomical boundaries:
- Lobar pneumonia: An entire lobe is consolidated (classic S. pneumoniae pattern).
- Bronchopneumonia (lobular): Patchy, multifocal consolidation surrounding bronchioles (S. aureus, gram-negative organisms).
In atypical pneumonia, the inflammatory process is primarily interstitial (within the alveolar walls and peribronchial tissue) rather than filling the alveolar spaces — producing the “interstitial” or “ground-glass” radiographic pattern characteristic of Mycoplasma and viral CAP.
Ventilation-Perfusion (V/Q) Mismatch and Hypoxemia
Consolidated alveoli are perfused by pulmonary capillary blood but cannot participate in gas exchange (they are filled with exudate, not air). This creates a V/Q mismatch — specifically, an increase in intrapulmonary shunt fraction — in which venous blood passes through non-ventilated lung units without being oxygenated. The result is hypoxemia (reduced PaO₂ and SpO₂) that may not respond adequately to supplemental oxygen alone, particularly when the shunt fraction exceeds 30%.
Simultaneously, the inflammatory response stimulates rapid, shallow breathing (tachypnea), which initially helps maintain PaCO₂ through hyperventilation, producing a respiratory alkalosis on arterial blood gas (ABG). As the patient fatigues or the infection progresses, hypercapnia (rising PaCO₂) signals impending respiratory failure.
Progression to ARDS and Sepsis
In severe CAP, the systemic inflammatory response may trigger:
- Acute Respiratory Distress Syndrome (ARDS): Diffuse bilateral lung injury with refractory hypoxemia (PaO₂/FiO₂ ratio < 300), bilateral infiltrates, and non-cardiogenic pulmonary edema. CAP is the most common direct cause of ARDS.
- Sepsis: Systemic organ dysfunction (Sepsis-3 criteria) resulting from the dysregulated host response to pulmonary infection. Bacteremic CAP — particularly pneumococcal pneumonia — is a major cause of sepsis and septic shock, carrying significantly higher mortality than non-bacteremic CAP.
Clinical Alert
Progressive tachypnea, worsening hypoxemia despite escalating oxygen delivery, rising lactate, and altered mental status in a patient with CAP signal impending respiratory failure and/or sepsis — escalate immediately.
Etiology & Pathogens
CAP pathogens are classified as typical or atypical based on the mechanism of lung injury, clinical presentation, and response to antibiotics. Viral etiologies comprise an increasing proportion of CAP, particularly following widespread influenza and SARS-CoV-2 surveillance.
Typical Bacterial Pathogens
| Pathogen | Epidemiology / Risk Factors | Classic Features | Radiographic Pattern |
|---|---|---|---|
| Streptococcus pneumoniae | Most common bacterial CAP; elderly, asplenic, immunocompromised, smokers | Acute onset; rust-colored (rusty) sputum; pleuritic chest pain; rigors; high fever | Lobar consolidation; air bronchograms |
| Haemophilus influenzae | COPD, smokers, elderly; non-typeable strains predominate | Purulent sputum; often exacerbates underlying lung disease | Bronchopneumonia; patchy |
| Staphylococcus aureus | Post-influenza infection; IV drug users; residents of LTCFs | Rapid progression; necrosis; empyema; high mortality | Bilateral patchy; cavitation/pneumatoceles; empyema |
| Klebsiella pneumoniae | Alcoholics; nursing home residents; diabetics | Abrupt onset; currant jelly sputum (bloody/mucoid); severe lobar consolidation; high mortality | Lobar; upper lobe; bulging fissure sign |
Atypical Bacterial Pathogens
| Pathogen | Epidemiology / Risk Factors | Classic Features | Radiographic Pattern |
|---|---|---|---|
| Mycoplasma pneumoniae | Young adults (15–40 years); college dormitories; closed communities | ”Walking pneumonia” — patient often ambulatory; gradual onset; dry (nonproductive) cough; headache; myalgia; extrapulmonary features (rash, hemolytic anemia) | Interstitial / ground-glass; patchy bilateral; worse than clinical exam suggests |
| Chlamydophila pneumoniae | Young to middle-aged adults; mild-moderate illness | Hoarse voice early; gradual onset; dry cough; prolonged convalescence | Patchy interstitial |
| Legionella pneumophila | Contaminated water sources (cooling towers, hotel/hospital water systems, spas); elderly; immunocompromised; smokers | High fever; relative bradycardia; hyponatremia (most specific lab finding); diarrhea; confusion; elevated LFTs | Rapidly progressive lobar/multilobar; Gram stain negative (does not Gram stain well) |
Viral Pathogens
| Pathogen | Key Features |
|---|---|
| Influenza A/B | Seasonal peaks; abrupt onset; myalgia; ± bacterial superinfection (S. aureus, S. pneumoniae); high risk of ARDS in elderly/immunocompromised |
| Respiratory Syncytial Virus (RSV) | Significant CAP burden in elderly and immunocompromised adults; often underdiagnosed |
| SARS-CoV-2 | Bilateral “ground-glass” opacities; cytokine storm; high ARDS and ICU risk; multisystem complications |
Note
Legionella diagnostic pearl: Legionella urinary antigen detects serogroup 1 (responsible for ~80% of Legionella CAP) rapidly and with high sensitivity/specificity. Standard Gram stain will be negative because Legionella requires specialized culture media (BCYE agar). Always order Legionella urinary antigen in severe CAP and in any patient with hyponatremia plus pneumonia.
Risk Factors
Certain patient characteristics substantially increase the risk of acquiring CAP, developing severe disease, or experiencing complications. The nurse should identify modifiable and non-modifiable risk factors to guide assessment priorities and targeted education.
| Category | Specific Risk Factors |
|---|---|
| Age | Age ≥ 65 years (impaired mucociliary clearance, diminished cough reflex, immunosenescence); infants and young children |
| Smoking | Impairs mucociliary clearance; damages respiratory epithelium; promotes oropharyngeal colonization with pathogens |
| Chronic lung disease | COPD, asthma, bronchiectasis — structural lung changes and chronic inflammation impair clearance |
| Immunosuppression | HIV/AIDS, malignancy, chemotherapy, long-term corticosteroids, organ transplant immunosuppression |
| Aspiration risk | Dysphagia, stroke, altered consciousness, gastroesophageal reflux, alcohol use disorder, seizure disorders |
| Comorbid conditions | Diabetes mellitus, heart failure, chronic renal disease, liver disease, malnutrition |
| Social/environmental | Congregate living (nursing homes, assisted living, correctional facilities, military barracks); homelessness; alcohol use disorder |
| Prior healthcare exposure | Hospitalization within the past 90 days; residency in a long-term care facility increases risk of drug-resistant organisms |
| Vaccination status | Lack of pneumococcal and/or influenza vaccination significantly increases CAP risk and severity |
Tip
Alcohol use disorder is specifically associated with Klebsiella pneumoniae (currant jelly sputum, severe lobar consolidation) and aspiration pneumonia. Identify alcohol use on admission — it changes your clinical suspicion about likely pathogens.
Clinical Presentation
Typical vs. Atypical Comparison
| Feature | Typical CAP | Atypical CAP |
|---|---|---|
| Onset | Abrupt (hours) | Gradual (days) |
| Fever | High (> 39°C); rigors/chills | Low-grade or absent |
| Cough | Productive; purulent or rust-colored sputum | Dry, nonproductive |
| Pleuritic chest pain | Common (especially pneumococcal) | Uncommon |
| Respiratory symptoms | Dominant presentation | Systemic symptoms may predominate |
| Extrapulmonary features | Uncommon | Common (headache, myalgia, GI symptoms, rash) |
| Auscultation | Crackles, bronchial breath sounds, egophony, decreased breath sounds over consolidation | May be disproportionately normal |
| Radiographic pattern | Lobar or segmental consolidation | Interstitial / bilateral ground-glass |
| WBC | Leukocytosis (typically > 15,000/μL) | Normal or mildly elevated |
| Gram stain | Organisms visible | Negative (Mycoplasma) or unremarkable |
| Causative organisms | S. pneumoniae, H. influenzae, S. aureus, K. pneumoniae | Mycoplasma, Chlamydophila, Legionella, viruses |
Classic Physical Examination Findings (Typical CAP)
- Fever: Temperature ≥ 38°C (100.4°F); may be accompanied by rigors (uncontrollable shaking chills — a hallmark of bacteremic pneumococcal pneumonia)
- Tachypnea: Respiratory rate ≥ 20–24 breaths/min; a key indicator of severity
- Tachycardia: Heart rate > 100 bpm; reflects the inflammatory and hypoxic burden
- Productive cough: Purulent, yellow-green, or rust-colored (pneumococcal) or currant jelly (Klebsiella) sputum
- Pleuritic chest pain: Sharp, localized pain worsened by inspiration or cough — indicates pleural involvement
- Auscultatory findings over the consolidated area:
- Crackles (rales): Fine, late-inspiratory crackling sounds from fluid in alveoli
- Bronchial breath sounds: Harsh, high-pitched breath sounds heard over consolidated (but patent bronchus) lung
- Egophony: “E” heard as “A” sound through stethoscope (“E-to-A” change)
- Increased tactile fremitus: Vibrations more pronounced over consolidation
- Percussion: Dullness to percussion over consolidated lung; absent over normal aerated lung
Older Adult Presentation
Clinical Alert
In older adults (age ≥ 65), classic CAP symptoms may be absent or markedly attenuated. Confusion or acute altered mental status may be the primary or only presenting symptom. Fever may be absent in up to 30% of elderly patients with CAP. A high index of suspicion is required — assess any older adult with new confusion for a pulmonary source.
Atypical presentations in older adults include:
- Acute confusion or delirium (most important atypical symptom)
- Falls — may precede or accompany acute illness
- Functional decline — increased dependence with activities of daily living
- Anorexia, nausea without prominent respiratory complaints
- Absence of fever or temperature that is elevated only relative to the patient’s baseline (e.g., 37.8°C in a patient whose baseline is 36.2°C)
- Blunted leukocytosis or even leukopenia in the frail elderly
Diagnostic Studies
Clinical Alert
Cultures MUST be obtained BEFORE antibiotic administration. Once antibiotics are started, the yield of blood cultures drops by 50–70% and sputum cultures may become negative within hours. This is the single most important nursing action in the diagnostic workup of CAP.
Imaging
| Study | Findings in CAP | Clinical Significance |
|---|---|---|
| Chest X-Ray (CXR) | Lobar consolidation (typical); interstitial/bilateral ground-glass (atypical/viral); patchy bronchopneumonia (S. aureus, gram-negatives); cavitation (S. aureus, K. pneumoniae) | Essential for diagnosis; required in all patients with suspected CAP; may lag 12–24 hours behind clinical symptoms |
| CT Chest | More sensitive for subtle consolidation, effusions, abscesses, and lymphadenopathy | Reserved for diagnostic uncertainty, immunocompromised patients, or suspected complications |
Laboratory Studies
| Study | Expected Finding | Clinical Significance |
|---|---|---|
| CBC with differential | Leukocytosis (WBC > 11,000/μL; left shift); leukopenia in severe/overwhelming infection or atypical organisms | Severity and immune response marker |
| Procalcitonin (PCT) | Elevated > 0.25 ng/mL suggests bacterial etiology; > 0.5 ng/mL supports antibiotic initiation | Guides antibiotic stewardship; serial values assist in de-escalation |
| C-reactive protein (CRP) | Markedly elevated in bacterial CAP | Non-specific marker of inflammation and severity |
| Sputum Gram stain and culture | Gram-positive diplococci (S. pneumoniae); gram-negative rods (H. influenzae, K. pneumoniae); no organisms (atypical) | Pathogen identification and sensitivity testing; obtain before first antibiotic dose |
| Blood cultures (×2 sets) | Positive in ~10–15% of hospitalized CAP (higher in severe disease and bacteremic pneumococcal pneumonia) | Essential for bacteremic CAP; guides de-escalation to targeted therapy; two sets from separate sites before antibiotics |
| Legionella urinary antigen | Positive in Legionella serogroup 1 infection | Rapid, highly sensitive/specific; indicated in all severe CAP and when hyponatremia is present |
| Pneumococcal urinary antigen | Positive in pneumococcal CAP | Rapid diagnosis; useful even after antibiotics started; recommended for all hospitalized CAP |
| Arterial Blood Gas (ABG) | Respiratory alkalosis early (low PaCO₂); hypoxemia (low PaO₂); rising PaCO₂ indicates fatigue/impending failure | Severity assessment; guides oxygen therapy decisions |
| BMP/CMP | BUN elevation (CURB-65 component); electrolyte abnormalities (hyponatremia in Legionella); creatinine (renal function) | Severity and organ function assessment |
| Lactate | Elevated in sepsis (> 2 mmol/L); > 4 mmol/L = septic shock | Tissue perfusion and sepsis severity |
| Influenza PCR / Respiratory viral panel | Positive in viral CAP | Guides infection control and antiviral therapy (oseltamivir for influenza) |
Note
SpO₂ by pulse oximetry is a continuous, non-invasive monitoring tool. An SpO₂ < 92% on room air is a threshold for supplemental oxygen in most CAP patients, and may indicate a need for urgent escalation of care. However, ABG provides definitive assessment of oxygenation, ventilation, and acid-base status that pulse oximetry cannot.
Risk Stratification
CURB-65 Score
The CURB-65 is the most widely used bedside tool for assessing CAP severity and determining appropriate care setting. Each criterion scores 1 point:
| Letter | Criterion | Score |
|---|---|---|
| C — Confusion | New onset confusion or disorientation (MMSE < 8 or new acute confusion) | 1 |
| U — Urea (BUN) | Blood urea nitrogen > 19 mg/dL (serum urea > 7 mmol/L) | 1 |
| R — Respiratory rate | ≥ 30 breaths/min | 1 |
| B — Blood pressure | Systolic < 90 mmHg OR diastolic ≤ 60 mmHg | 1 |
| 65 — Age | ≥ 65 years | 1 |
Total possible score: 5
| CURB-65 Score | Mortality Risk | Recommended Disposition |
|---|---|---|
| 0–1 | Low (< 3%) | Outpatient treatment appropriate |
| 2 | Moderate (~9%) | Consider hospitalization or closely supervised outpatient with next-day follow-up |
| 3 | High (~17%) | Hospitalize on medical-surgical unit |
| 4–5 | Very high (> 30–40%) | Hospitalize; consider ICU evaluation |
Note
CURB-65 is a clinical adjunct, not a replacement for clinical judgment. A patient with CURB-65 score of 1 who is hypoxic (SpO₂ < 92%), cannot maintain oral intake, or has significant comorbidities should be strongly considered for hospitalization. The PSI (Pneumonia Severity Index / PORT score) provides a more granular risk assessment but is more complex to calculate at the bedside.
Clinical Stability Criteria for Discharge
Patients hospitalized with CAP may be safely transitioned to outpatient care when they meet all of the following criteria (ATS/IDSA):
- Temperature ≤ 37.8°C (100°F)
- Heart rate ≤ 100 bpm
- Respiratory rate ≤ 24 breaths/min
- Systolic BP ≥ 90 mmHg
- SpO₂ ≥ 90% on room air (or baseline)
- Normal mentation (at baseline)
- Tolerating oral intake
Nursing Assessment
Respiratory Assessment Priorities
A systematic, head-to-toe respiratory assessment is the cornerstone of CAP nursing management. Reassessment frequency should be matched to patient acuity — at minimum every 4 hours on a medical-surgical unit; every 1–2 hours or continuously in the ICU.
Key respiratory assessment parameters:
- Respiratory rate and pattern: The respiratory rate is the earliest and most sensitive vital sign indicator of deterioration in respiratory illness. A rate ≥ 30 breaths/min is a danger sign requiring immediate escalation.
- SpO₂: Continuous pulse oximetry; target ≥ 92–94% (95% in most non-COPD patients). Trend over time.
- Work of breathing: Observe for use of accessory muscles (sternocleidomastoid, scalenes, intercostals), nasal flaring, pursed-lip breathing, tripod positioning — all indicate increased respiratory effort and impending fatigue.
- Breath sounds: Auscultate all lung fields systematically. Document crackles, bronchial breath sounds, decreased/absent breath sounds (consolidation, effusion, pneumothorax), and wheezing.
- Cough effectiveness: Assess ability to generate an effective cough and clear secretions; note sputum color, consistency, and quantity.
- Skin color and perfusion: Central and peripheral cyanosis indicates severe hypoxemia; mottled skin and prolonged capillary refill suggest circulatory compromise.
Signs of Deterioration — Escalate Immediately
Clinical Alert
The following findings in a patient with CAP require immediate provider notification and urgent reassessment:
- Respiratory rate ≥ 30 breaths/min (or increasing trend)
- SpO₂ < 90% (or < baseline) despite supplemental oxygen
- Accessory muscle use or paradoxical breathing
- New or worsening confusion / altered mental status
- Systolic BP < 90 mmHg or MAP < 65 mmHg
- Heart rate > 120 bpm or new dysrhythmia
- Failure of supplemental oxygen to maintain adequate SpO₂
Additional Assessment Domains
- Vital sign trends: Serial temperature monitoring; fever curve tracking; response to antipyretics; new or persistent fever after 72 hours of antibiotics raises concern for resistant organisms, empyema, or non-infectious etiology.
- Fluid status: Daily weights; intake and output (I&O); assess for dehydration (dry mucous membranes, skin tenting, concentrated urine, orthostasis) or volume overload (peripheral edema, crackles, elevated JVP).
- Nutritional status: Malnutrition impairs immune function and prolongs recovery; assess appetite, oral intake, albumin, and prealbumin; involve dietitian early.
- Functional status: Pre-illness functional baseline (especially in older adults); assess need for physical and occupational therapy; fall risk secondary to deconditioning, hypoxia, and medication effects.
- Pain assessment: Pleuritic chest pain may inhibit deep breathing and effective coughing, leading to hypoventilation and atelectasis; assess pain at rest and with breathing, and medicate adequately.
Nursing Interventions
Oxygenation Management
Oxygen therapy in CAP is titrated to maintain SpO₂ ≥ 92–94% in most patients (≥ 88–92% in COPD with known hypercapnic respiratory failure). The nurse selects and escalates the oxygen delivery device based on the patient’s SpO₂, work of breathing, and clinical trajectory.
| Oxygen Delivery Device | FiO₂ Range | Flow Rate | Clinical Indication |
|---|---|---|---|
| Nasal cannula (NC) | 24–44% | 1–6 L/min | Mild hypoxemia; SpO₂ 90–94% on room air |
| Simple face mask | 35–50% | 6–10 L/min | Moderate hypoxemia when NC insufficient |
| Partial rebreather mask | 40–70% | 6–10 L/min | Moderate-severe hypoxemia |
| Non-rebreather mask (NRB) | 60–80% (up to ~90%) | 10–15 L/min | Severe hypoxemia; bridge to intubation or HFNC |
| High-Flow Nasal Cannula (HFNC) | 21–100% | 20–60 L/min | Severe hypoxemia; reduces intubation rates in some CAP; preferred in hypoxemic respiratory failure |
| Non-invasive positive pressure ventilation (CPAP/BiPAP) | Variable | — | Select patients; use with caution in CAP (evidence limited vs. HFNC) |
| Endotracheal intubation / MV | 21–100% | — | Respiratory failure; unable to maintain oxygenation with non-invasive means |
Clinical Alert
SpO₂ < 92% requires intervention. Do NOT wait for an ABG to escalate oxygen delivery when pulse oximetry shows progressive or sustained desaturation.
Positioning
- Semi-Fowler’s position (30–45°): Reduces abdominal pressure on the diaphragm, facilitates lung expansion, and decreases aspiration risk. Default positioning for all alert CAP patients.
- Lateral positioning (good lung down): For unilateral pneumonia, position the patient with the healthy (less affected) lung in the dependent position to maximize ventilation to the best lung and optimize V/Q matching. This is the opposite of the positioning used for secretion drainage.
- Prone positioning: Reserved for severe ARDS (PaO₂/FiO₂ < 150) per provider order and institutional protocol; requires specialized team and prone positioning equipment.
Incentive Spirometry
- Encourage deep breathing using an incentive spirometer every 1–2 hours while awake.
- Goal: Volume-oriented IS devices target ≥ 70% of predicted inspiratory capacity.
- Rationale: Deep breathing recruits collapsed (atelectatic) alveoli adjacent to consolidated areas, improves oxygenation, and promotes cough.
- Document volume achieved; coach the patient on correct technique — slow, maximal inspiration, 3-second hold, then passive exhalation.
Fluid Management
- Maintain adequate hydration to thin secretions and support mucociliary clearance; typical target: 2–3 L/day oral or IV fluids unless contraindicated (heart failure, renal disease).
- IV fluid resuscitation is indicated in the patient with CAP and hemodynamic instability (MAP < 65 mmHg, signs of hypoperfusion) per sepsis protocols.
- Monitor I&O, daily weight, BUN, creatinine, and electrolytes.
Early Mobility
- Initiate early mobility (dangling, chair sitting, ambulation) as soon as the patient is hemodynamically stable and oxygenation can be maintained.
- Early ambulation reduces pneumonia-related complications, improves respiratory mechanics, and shortens hospital length of stay.
- Collaborate with physical therapy for patients with functional limitations or deconditioning.
Infection Control Precautions
| Pathogen | Transmission-Based Precaution |
|---|---|
| Most bacterial CAP (S. pneumoniae, H. influenzae) | Standard Precautions only |
| Influenza virus | Droplet Precautions (surgical mask for HCP within 6 feet; private room preferred) |
| SARS-CoV-2 | Droplet + Contact Precautions (N95 for aerosol-generating procedures) |
| Mycobacterium tuberculosis (must exclude TB) | Airborne Precautions (N95 respirator; negative pressure room) until TB excluded |
Note
CAP due to most common bacterial pathogens does not require transmission-based precautions beyond standard precautions. However, always consider tuberculosis in the differential diagnosis of pulmonary infiltrates, especially in immunocompromised patients or those with risk factors; place in airborne precautions until TB is excluded.
Aspiration Precautions
- Elevate head of bed ≥ 30° at all times; 45° during oral intake and for 30 minutes after.
- Assess swallowing function before any oral intake, particularly in post-stroke patients, elderly patients with delirium, or those with a history of dysphagia.
- Ensure dentures are in place before meals if applicable.
- Thicken liquids per speech-language pathology recommendation as needed.
- Avoid sedating medications that suppress the cough or gag reflex unless clinically required.
Pharmacological Considerations
Antibiotic Selection by Severity Category
Antibiotic selection follows the ATS/IDSA 2019 CAP Guidelines and is based on disease severity, care setting, presence of comorbidities, and local resistance patterns.
Outpatient — No Comorbidities, Low-Risk
| First-Line Option | Dose | Duration | Notes |
|---|---|---|---|
| Amoxicillin | 1 g PO TID | 5 days | Preferred; targets S. pneumoniae; inexpensive |
| Azithromycin | 500 mg PO day 1, then 250 mg days 2–5 | 5 days | Use only when macrolide resistance < 25% locally |
| Doxycycline | 100 mg PO BID | 5 days | Alternative; covers some atypicals |
Outpatient — With Comorbidities (COPD, Diabetes, Cardiac/Renal/Hepatic Disease, Immunosuppression, Malignancy, Alcoholism)
| First-Line Option | Regimen | Notes |
|---|---|---|
| Amoxicillin-clavulanate + macrolide | Amoxicillin-clavulanate 875/125 mg PO BID + azithromycin 500 mg day 1 then 250 mg days 2–5 | Broader spectrum; covers beta-lactamase producers |
| Respiratory fluoroquinolone (monotherapy) | Levofloxacin 750 mg PO daily × 5 days OR moxifloxacin 400 mg PO daily × 5 days | Convenient monotherapy; covers atypicals; use cautiously — reserve to limit resistance |
Hospitalized — Non-ICU
| Preferred Regimen | Regimen | Notes |
|---|---|---|
| Beta-lactam + macrolide | Ceftriaxone 1–2 g IV daily + azithromycin 500 mg IV/PO daily | Standard of care for most hospitalized non-ICU CAP |
| Respiratory fluoroquinolone monotherapy | Levofloxacin 750 mg IV/PO daily × 5 days | Alternative; use when macrolide contraindicated or allergy |
Hospitalized — ICU / Severe CAP
| Regimen | Indication |
|---|---|
| Beta-lactam + azithromycin OR fluoroquinolone | Standard severe CAP without MRSA risk factors |
| + Vancomycin or linezolid | Add when MRSA risk factors present: prior MRSA infection/colonization, recent influenza, cavitary/necrotizing pneumonia, prior antibiotic use |
| + Antipseudomonal beta-lactam (piperacillin-tazobactam, cefepime) | Add for structural lung disease (bronchiectasis), recent broad-spectrum antibiotics, Pseudomonas risk |
Duration
- 5 days if patient achieves clinical stability by day 3 (temperature ≤ 37.8°C, HR ≤ 100, RR ≤ 24, SpO₂ ≥ 90%, tolerating oral intake, normal mentation).
- Extend to 7 days for bacteremic pneumonia or if clinical stability not achieved.
- Culture-guided de-escalation to the narrowest effective spectrum as soon as susceptibility results are available — essential for antibiotic stewardship.
Nursing Implications by Drug Class
| Drug Class | Examples | Key Nursing Implications |
|---|---|---|
| Beta-lactams (penicillins) | Amoxicillin, amoxicillin-clavulanate, ampicillin-sulbactam | Assess penicillin allergy history; true anaphylactic penicillin allergy contraindicates; cross-reactivity with cephalosporins is low (~1–2%) |
| Cephalosporins | Ceftriaxone, cefdinir, cefpodoxime | Monitor for hypersensitivity; IM ceftriaxone painful — use IV in hospitalized patients; once-daily dosing improves adherence |
| Macrolides | Azithromycin, clarithromycin | Assess for QTc prolongation (order baseline ECG if risk factors); azithromycin interacts with antiarrhythmics; GI side effects (nausea) common — give with food |
| Fluoroquinolones | Levofloxacin, moxifloxacin | QTc prolongation risk; tendon rupture risk (especially with concurrent corticosteroids, elderly patients); avoid in pregnancy; drug interactions with antacids (separate by 2 hours) |
| Tetracyclines | Doxycycline | Do not give with dairy, antacids, or iron (chelation); photosensitivity — advise sun protection; avoid in pregnancy and children < 8 years |
| Vancomycin | Vancomycin IV | Monitor trough levels (target AUC/MIC-guided dosing) or trough of 15–20 mcg/mL; infuse over at least 60 minutes to prevent Red Man syndrome; nephrotoxic — monitor BUN/creatinine and I&O |
Tip
Apply antibiotic stewardship principles: confirm clinical stability at 72 hours and narrow therapy based on culture results. Stopping antibiotics when appropriate is as important as starting them promptly.
Complications
Parapneumonic Effusion and Empyema
- Parapneumonic effusion: Fluid accumulation in the pleural space adjacent to the pneumonia, occurring in 20–40% of hospitalized CAP cases. Most are small and exudative, resolving with antibiotics.
- Empyema: Frank pus in the pleural space; requires chest tube drainage (thoracentesis or tube thoracostomy) plus prolonged antibiotic therapy. Assess daily for signs: persistent fever despite antibiotics, pleuritic chest pain, decreased breath sounds with dullness to percussion, increasing pleural fluid on imaging. Empyema is a surgical emergency if loculated or not draining freely.
Lung Abscess
- Necrotic cavity within the lung parenchyma, usually resulting from aspiration or virulent pathogens (S. aureus, anaerobes, K. pneumoniae).
- Classic presentation: foul-smelling/putrid sputum, prolonged fever, weight loss, and a thick-walled cavitary lesion on CXR or CT.
- Treatment: prolonged antibiotic therapy (4–6 weeks); surgical drainage if refractory. Nursing: high aspiration risk — meticulous aspiration precautions, positioning, oral hygiene.
Bacteremia and Sepsis
- CAP is the most common precipitant of community-acquired sepsis in the United States.
- Bacteremia (positive blood cultures) complicates 10–15% of hospitalized CAP; pneumococcal bacteremia carries a 20–30% mortality rate.
- Apply Surviving Sepsis Campaign Hour-1 Bundle if sepsis criteria are met: measure lactate, obtain blood cultures, administer broad-spectrum antibiotics, initiate IV fluid resuscitation, apply vasopressors for refractory hypotension.
Acute Respiratory Distress Syndrome (ARDS)
- CAP is the single most common direct (pulmonary) cause of ARDS.
- ARDS criteria: acute onset; bilateral infiltrates on CXR; PaO₂/FiO₂ ratio < 300; not explained by cardiac failure.
- Nursing management of ARDS includes: lung-protective mechanical ventilation (tidal volume 4–8 mL/kg IBW, plateau pressure < 30 cmH₂O), prone positioning per protocol, conservative fluid strategy, and prevention of ventilator-associated complications (VAP bundle, daily sedation interruption trials).
Respiratory Failure
- Hypoxemic respiratory failure (Type 1): low PaO₂ with normal or low PaCO₂; V/Q mismatch predominates.
- Hypercapnic respiratory failure (Type 2): rising PaCO₂ as respiratory muscles fatigue; signals impending need for mechanical ventilatory support.
- Early identification of deterioration and escalation of respiratory support is the nurse’s most critical intervention in preventing respiratory failure–related death.
Patient Education
Vaccination
Pneumonia is largely preventable. Vaccination counseling is a priority nursing intervention for all patients recovering from CAP.
| Vaccine | Recommendation | Nursing Teaching Points |
|---|---|---|
| PCV15 or PCV20 (Pneumococcal conjugate) | All adults ≥ 65 years; adults 19–64 with immunocompromising conditions, CSF leaks, cochlear implants | Single dose; given regardless of prior pneumococcal vaccination history in eligible adults; PCV20 provides broader serotype coverage |
| PPSV23 (Pneumococcal polysaccharide) | If PCV15 given at ≥ 65: give PPSV23 ≥ 1 year later; if given before 65 for risk condition: revaccinate at 65 (minimum 5 years between doses) | May be recommended in addition to conjugate vaccine for highest-risk adults |
| Influenza | Annual vaccination; all adults ≥ 6 months | September–October timing; influenza-associated pneumonia and secondary bacterial pneumonia (S. aureus, S. pneumoniae) are vaccine-preventable |
| COVID-19 | Per current CDC schedule | SARS-CoV-2 is a significant CAP pathogen; updated bivalent/monovalent boosters recommended |
Antibiotic Completion
- Emphasize that the full antibiotic course must be completed even if feeling better after 2–3 days, to prevent relapse and selection of resistant organisms.
- Review timing, food interactions, and storage for all prescribed antibiotics.
- Teach patient to call their provider (not stop antibiotics independently) if side effects develop.
Smoking Cessation
- Smoking is the most important modifiable risk factor for CAP; smokers have 4-fold increased risk.
- Provide brief cessation counseling using the 5 A’s framework (Ask, Advise, Assess, Assist, Arrange).
- Offer NRT, varenicline, or bupropion per provider order; refer to state quitline (1-800-QUIT-NOW).
Return to Emergency Department Criteria
Teach patients to return immediately or call 911 if experiencing:
- Worsening shortness of breath or difficulty breathing
- SpO₂ < 92% (if home pulse oximeter prescribed)
- Confusion, severe headache, or inability to be aroused
- Temperature > 39.4°C (103°F) despite antipyretics
- Chest pain that is new or worsening
- Inability to keep down fluids or oral medications
- No improvement after 72 hours on antibiotics
Follow-Up Chest X-Ray
- Radiographic clearance of pneumonia lags behind clinical improvement by weeks.
- Routine follow-up CXR is recommended at 6–8 weeks post-treatment in adults ≥ 40 years and in smokers to ensure complete resolution and rule out an underlying malignancy (post-obstructive pneumonia from an endobronchial lesion can mimic CAP).
NCLEX Formative Check
Use these NGN-style questions to test clinical judgment skills related to CAP. Answers and rationales follow each question.
Question 1 — Extended Multiple Response (Select All That Apply)
Clinical scenario: A 72-year-old male with a history of COPD and alcohol use disorder presents to the emergency department. His wife reports he has been “confused and not himself” for 2 days. He has not complained of chest pain or cough. Vital signs: T 37.4°C, HR 112 bpm, RR 28 breaths/min, BP 96/58 mmHg, SpO₂ 87% on room air. Physical exam reveals dullness to percussion at the right base, decreased breath sounds right lower lobe, and crackles. CXR shows right lower lobe consolidation. BUN is 26 mg/dL.
Question: Which of the following nursing actions are the highest priority at this time? Select all that apply.
- A. Administer azithromycin 500 mg IV as ordered
- B. Obtain two sets of blood cultures from separate venipuncture sites
- C. Apply oxygen via non-rebreather mask and titrate to SpO₂ ≥ 92%
- D. Place the patient in a right lateral decubitus position (right side down)
- E. Calculate the patient’s CURB-65 score and notify the provider
- F. Collect a sputum specimen for Gram stain and culture
- G. Order a pulmonary function test to assess COPD severity
- H. Send Legionella urinary antigen and pneumococcal urinary antigen
Correct answers: B, C, E, F, H
Rationale: This patient has severe CAP with signs of sepsis (altered mental status, tachycardia, tachypnea, hypotension) and an SpO₂ of 87% — immediate intervention is required. Blood cultures (B) and sputum culture (F) must be obtained before antibiotic administration to preserve diagnostic yield — this is a critical sequencing priority. Supplemental oxygen (C) is urgent given SpO₂ 87%, with a target ≥ 92%. CURB-65 calculation (E) — this patient scores 4 (Confusion + BUN > 19 + RR ≥ 30 + BP systolic < 90 + Age ≥ 65) — should be communicated immediately to trigger ICU evaluation. Urinary antigens (H) should be sent given age, COPD, alcohol use, and severe disease. Azithromycin (A) is correct therapy but must be preceded by culture collection — answer A is not the highest priority until cultures are drawn. Right lateral decubitus positioning (D) places the affected lung down, which worsens V/Q mismatch in this setting — the good lung should be dependent. Pulmonary function testing (G) is not appropriate in acute illness.
Question 2 — Drop-Down Cloze
Clinical scenario: A 28-year-old college student presents to the student health clinic with a 10-day history of fatigue, low-grade fever (37.8°C), dry persistent cough, and mild headache. She reports “I keep going to class because I don’t feel sick enough to stay home.” Chest X-ray shows bilateral patchy interstitial infiltrates. WBC is 8,900/μL (normal). Gram stain of sputum is negative for organisms.
Question: The nurse recognizes this presentation as most consistent with ____ pneumonia caused by ____, and knows that the treatment of choice is ____.
Option set for blank 1: Typical / Atypical / Fungal / Aspiration
Option set for blank 2: Streptococcus pneumoniae / Mycoplasma pneumoniae / Legionella pneumophila / Staphylococcus aureus
Option set for blank 3: Ceftriaxone IV + azithromycin IV / Amoxicillin PO / Azithromycin or doxycycline PO / Vancomycin IV
Correct answers: Atypical; Mycoplasma pneumoniae; Azithromycin or doxycycline PO
Rationale: The clinical picture — young adult, gradual onset, dry cough, ambulatory (“walking pneumonia”), low-grade fever, normal WBC, bilateral interstitial pattern, and negative Gram stain — is classic for atypical CAP caused by Mycoplasma pneumoniae. Atypical organisms lack a cell wall (Mycoplasma) or do not Gram stain reliably (Legionella), which explains the negative Gram stain. Treatment targets intracellular organisms: macrolides (azithromycin) and tetracyclines (doxycycline) are first-line. Beta-lactams (amoxicillin, ceftriaxone) are ineffective against Mycoplasma because it has no cell wall.
Question 3 — Matrix/Grid (Multiple Choice Per Row)
Clinical scenario: A nurse is caring for a 68-year-old female with CAP admitted 48 hours ago. She is currently on ceftriaxone 1 g IV daily and azithromycin 500 mg IV daily. The provider asks the nurse to evaluate whether she meets criteria for clinical stability and antibiotic de-escalation.
Current assessment: T 37.5°C, HR 88 bpm, RR 20 breaths/min, BP 122/74 mmHg, SpO₂ 94% on 2 L/min NC, alert and oriented × 4, tolerating clear liquids.
Question: For each assessment finding below, indicate whether the finding Meets or Does Not Meet the ATS/IDSA clinical stability criterion.
| Finding | Meets Criterion | Does Not Meet Criterion |
|---|---|---|
| Temperature 37.5°C | ✓ | |
| Heart rate 88 bpm | ✓ | |
| Respiratory rate 20 breaths/min | ✓ | |
| SpO₂ 94% on 2 L/min nasal cannula | ✓ | |
| Tolerating clear liquids | ✓ |
Rationale: Temperature ≤ 37.8°C ✓; HR ≤ 100 bpm ✓; RR ≤ 24 breaths/min ✓; Tolerating oral intake ✓. SpO₂ 94% on supplemental oxygen (2 L/min NC) does NOT meet the criterion — the ATS/IDSA criterion requires SpO₂ ≥ 90% on room air (or at the patient’s baseline). This patient requires supplemental oxygen to maintain her SpO₂, meaning she has not yet met pulmonary stability criteria and should not yet be transitioned to oral antibiotics or discharged. The provider should be notified that full clinical stability has not been achieved.
Note
These NGN-style questions target the Clinical Judgment Measurement Model layers of Recognize Cues (Q1, Q3), Analyze Cues (Q2), Prioritize Hypotheses (Q1), and Take Action (Q1). For further NCLEX-NG CAP preparation, review the ATS/IDSA 2019 CAP Guidelines and NCSBN NGN practice resources.
Standards Alignment Summary
This entry directly supports the following accreditation and professional standards:
- AACN Essentials (2021): Domain 1 (Knowledge for Nursing Practice), Domain 2 (Person-Centered Care), Domain 3 (Population Health), Domain 4 (Scholarship for Nursing Practice), Domain 9 (Professionalism)
- NCLEX-NG Clinical Judgment Measurement Model: Recognize Cues, Analyze Cues, Prioritize Hypotheses, Generate Solutions, Take Action, Evaluate Outcomes
- QSEN Competencies: Patient-Centered Care (PCC), Evidence-Based Practice (EBP), Safety (S), Quality Improvement (QI)
- CCNE Standards: I (mission and integrity), II (institutional resources), III (curriculum and teaching-learning practices)
- ACEN Standards: 3 (curriculum), 4 (faculty and staff)
References
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67. https://doi.org/10.1164/rccm.201908-1581ST
Wunderink, R. G., & Waterer, G. (2017). Community-acquired pneumonia: Pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. Infectious Disease Clinics of North America, 31(1), 1–12. https://doi.org/10.1016/j.idc.2016.10.001
File, T. M. (2023). Community-acquired pneumonia in adults. In UpToDate. Wolters Kluwer. Retrieved March 27, 2026.
Centers for Disease Control and Prevention. (2024). Pneumococcal vaccination: What everyone should know. https://www.cdc.gov/vaccines/vpd/pneumo/public/index.html
Lim, W. S., van der Eerden, M. M., Laing, R., Boersma, W. G., Karalus, N., Town, G. I., Lewis, S. A., & Macfarlane, J. T. (2003). Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax, 58(5), 377–382. https://doi.org/10.1136/thorax.58.5.377
American Association of Colleges of Nursing. (2021). The essentials: Core competencies for professional nursing education. AACN. https://www.aacnnursing.org/Portals/0/PDFs/Publications/Essentials-2021.pdf
National Council of State Boards of Nursing. (2023). NCLEX-RN examination: Test plan for the national council licensure examination for registered nurses. NCSBN.
Surviving Sepsis Campaign. (2021). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Society of Critical Care Medicine. https://doi.org/10.1097/CCM.0000000000005337
Related Content
Encyclopedia
Courses